Search

Your search keyword '"gastrointestinal manifestations"' showing total 6 results
Start Over Descriptor "gastrointestinal manifestations" Publisher springer us
6 results on '"gastrointestinal manifestations"'

2. Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study

Author

Ashktorab, Hassan, Challa, Suryanarayana Reddy, Singh, Gagan, Nanduri, Sumant, Ibrahim, Malika, Martirosyan, Zara, Whitsell, Peter, Chirumamilla, Lakshmi G., Shayegh, Nader, Watson, Kyra, Smith, Tori, Ogwo, Valarie, Kolawole, Oluwapelumi, Littleton, Megan, Morrison, Nicole, Nair, Vaisakh, Byer, Danae, Dawodu, Dideolu O., Lexima, Patrice, Rashid, Mudasir, Deverapalli, Mrinalini, Atluri, Swetha Mynedi, Nezamloo, Ali, Nasrin, Farjana, Kim, Rachel Ji-Aeh, Sherif, Zaki, Oskrochi, Gholamreza, Carethers, John M., and Brim, H.

Published
2024
Full Text
View/download PDF

5. Impact of COVID-19 on the Intestinal Microbiome

Author

Carla Venegas-Borsellino, Ryan Michael Landis, Keelin Roche, JBracken Burns, and Senthilkumar Sankararaman

Subjects
Clinical nutrition, Cytokine release syndrome, Diabetes mellitus, medicine, Gastrointestinal manifestations, Humans, Microbiome, Brain-gut axis, Risk factor, Respiratory system, Nutrition and Dietetics, business.industry, SARS-CoV-2, Probiotics, COVID-19, medicine.disease, Review article, Gastrointestinal Microbiome, Gastrointestinal Tract, Immunology, Dysbiosis, Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave and M Eisa, Section Editors), business, Homeostasis, Food Science
Abstract

Purpose of Review This review article aims to explore the GI changes induced by SARS-CoV-2 and how gut microbial homeostasis can influence these changes and affect the lung-gut axis and its relationship with the induction of the cytokine release syndrome in severe COVID-19 patients. Recent Findings Coronavirus disease 2019 (COVID-19) affects not only the respiratory system but can produce multi-systemic damage. The expression of angiotensin-converting enzyme 2 (ACE-2) receptors in the gastrointestinal (GI) tract, the high prevalence of GI symptoms in severely ill COVID-19 patients, and the abnormalities described in the gut microbiome in these patients have raised concerns about the influence of GI tract as a risk factor or as a potential modulator to reduce the severity of COVID-19. Summary Understanding the mechanisms by which gut dysbiosis may influence viral transmission and disease progression in COVID-19 may help in shaping how accessible therapies, like diet modulation, can potentially help beat the devastating consequences of COVID-19.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results